Академический Документы
Профессиональный Документы
Культура Документы
Haematology
item
drugs
iron deficiency
HCL
absorbtion
iron
achlorhydria
iron deficiency
iron
hemorrhage
anticoagulant
bleeding
deficiency anemia
B6 metabolism
methotrexate
absorption
Inh
drugs
sideroblastic
folic acid
sulphonamide
antis
activation
anemia
and antiepileptic
G6PD
hemolytic anemia
hemolysis
iron parentral
amphotercin
PNH
antigen
RBCs
incomplete antigen
antigen
immune system
HAptin
penicillin
antigen
RBCs
Coagulation or homeostasis
coagulation or homeostasis
Mechanism by which the body stops bleeding
Mechanism
bleeding
hemorrhage
hemorrhage
platlets
BloodVessels
clotting system
BloodVessel
vasoconstriction
vasoconstriction
blood vessels
activated
BloodVessel
stasis
bleeding
vasoconstriction
injury
injury
blood vessels
injury
reflex vasoconstriction
irritation
serotonin
VC
response
platelets
platlets
megakryocytes
megakryocytes
BoneMarrow
budding
alpha and dense
granules
nucleas
Platelets
megakryocytes
granules
5
11
platelets
011
111
platlets
which means
Platelets
Platelets
factor 8
VWbrandfactor
adhesions
wall
Injury
Glycoprotein receptor
receptor
endothelium
platelet
Platelets
platlet aggregatons
step
GP2b/3a
protein
fibrin
Prostaglandin
TXA2
ThromboxaneA2
aggregations
Prostaglandin
antiplatlet
aspirin
platelets aggregations
granules
granules
platelets
step of secretions
serotonin
VC
serotonin
aggregations
coagulation factors
clot
activation
wall
contents
ADP
Platelets
platelet factor 3
secretions
blood clot
clot
step
retractozyme
retractozyme
function of platelet
coagulation
not all of them
liver
factor 13
11 7 9 2
activation
1792
liver
not activated
endothelium
7 activate
11
injury
activate 11
liver
activation
is lined be endothelium
endothelium
ca
vit k
?
collagen
coagulation
12
CoagulationFactors
blood vessels
endothelium
collagen
12 activate
collagen
calcium + Platelets factor 3 & 8
intrinsic pathway
component
3 9
11
3 9
tissues
Extrinsic pathway
pathway
11
trauma
3
extrinsic
common pathway
fibrinogen into
thrombin
pathway 2
prothrombin to thrombin
RBCs wbcs and platelet
11
11
common pathway
fibrin
fibrin
Anticoagulant system
anti- coagulation system
coagulation system
balamce
blood
extend
balance
thrombus
coagulation system
thrombus
anti coagulation
anti coagulant
vasoconstriction
antagonize
endothelium
vasodilatation
platelets
intrinsic pathway
extrinsic pathway
anti coagulation
prostacyclin
wall of bv
collagen
vessels
inhibition
endothelium
activation
endothelium
endothelium
antithromibn 3
endothelium
common pathway
pathway 3
endothelium
fibrinolysis
tPA
anti coagulant
anti coagulant
coagulation factors
coagulation factor
liver
VIT K
liver
anti coagulant
VIT K
protein C & S
balance
anticoagulation factor
activated
factor activated
injury
liver
active factor
active
Basics
general rules
General Rules
coagulation
blood vessels , Platelets or coagulation factors
disease
etiology
purpra
color
red spots
Clinical picture
petechaie
change
color changes
Platelets
bv
, bleeding gums perifollicular hemorrhage
hair follicles
without
spontenous
external hemorrhage
hemorrhage
hemorrhage
cerebral hemorrhage
Hemorhhage
petechie
anemia
trauma
disease
picture
anemia
coagulation
raised
ecchymosis
hematoma
external hemorrhage
internal hemorrhage
Internal hemorrhage
hemophilia
coagulation congenital
hemoarthrosis
joint
congenital
hemorrhage
congenital
trauma
bleeding
hemorrhage
umbilical cord
detected
supplying baby
cp
bv and Platelets
epistaxis
clinically
overlap
bv and Platelets
hematoma
investigations not cp
petechie
hematologist
Investigations
Open heart
ICU
011
pericardium
tube
011
medical
medical
suture
medical or surgical
complications
investigations
1
bleeding time
=D
bleeding
platelet
same effect
Bleeding
blood vessels or Platelets
abnormal
prolonged
platelet count function
bleeding time
2- 4 minuits
clotting time
clotting time
prolonged
bleeding time
in 5 10 minuits
surgical
anatomical ,
7 clotting time
coagulation
9 bleeding time
bV
Platelets
blood vessels
Platelets
11
common
extrinsic
Intrinsic
collagen
7
coagulation
PTT
, , 7 activate 11
, 11 activate 12 activate 12
thrombin
coagulation
PT
PTT
collagen
intrinsic
ptt
3 9
blood clot
11
PT
3 9
brain
extrinsic
thrombin
prothrombin to thrombin
clotting time
PT abnormal
ptt
PT normal
common pathway
, intrinsic
clotting
PTT abnormal
Abnormal
PT normal
PTT abnormal
12
1221127
11
deficiency
test normal
11
50 mg
mg 11
ratio between PT
brain tissue
rabit
second 16
rabit
intrinsic
12
PT
rabit
activate
15 seconds
intrinsic
11
pathway
pathway
extrinsic
test
11 activate
blood clot
tissue factor
abnormal
11
PT
activate
30 seconds
pathway
prothrombin to thrombin
pt and ptt
INR
12
PT
content
rabbit
brain tissue
tissue
brain tissue
10 PT
Tissue
11
11 PT
Tissue variable from one to another
41
Brain tissue
10
ratio
16
32
PT
12
20
2 INR
2
PT control
PT
=D 125 INR
2-3 times
PTT
INR
12
INR 2
3
20
PT
heparin
:D
PTT
Anticoagulant
fibrinogen le fibrin
PT
thrombin
normal
tesathrombin
fibrinogen bs
obsolete
clot
Treatment
Bleeding tendency
Avoid trauma , avoid injury
Avoid unnecessary surgeries
Avoid aspirin
Vascular purpra
vascular purpra
blood vessels
Platelets
blood vessels
Platelets
purpra
blood vessels
vascular purpra
congenital
congenital weakness in wall of blood
features
blood vessels dilated
telengectasia
vasoconstriction in response to trauma
GIT hemorrhage
marfan
typical
vessels
Acquired
I M
blood vessels
vit c deficnecy
scurvy
acquired
hypertension
collagen
acquired
Mechanical
Mesenchymal weakness
scurvy , perifollicular
old age
hemorrhage
steroid ttt and cushing
fast food
I
plague
Infections
SLE
collagen disease
Inflammation
Immunological
Idiopathic
rheumatic fever
story of
immune complex
blood
blood vessels
antigen
heart
Antibodies
complex
against organism
Rheumatic fever
rheumatic fever
vasculitis
IgA
it doesnt take that
11 3
Henoch schonlein
IgG& IgM
Henoch schonlein
vessels
Rheumatic fever
Rheumatic fever
long time
Clinical picture
3
petechie
Purpra
blood vessels
buttocks
color changes
cerebral hemorrhage
external hemorrhage
periarticular
arthritis
internal hemorrhage
D.D of intusseption
joint
GIT
joint
hemorrhage
rheumatic fever
spontenous without trauma
glomeruli
blood vessels
glomerulonephritis
hemorrhage
characterstic
Investigations
Bleeding time
Normal PT,PTT, Platelet count
RBCs cast in urine
specific
Treatment
corticosteroids
Platelets
blood vessels
Platelets defect
3
Thrombocytopenia
Thromboasthenia
Thromobcytosis
decrease in Platelets count
Thrombocytopenia
defect in function
Thromboasthenia
Thromobcytosis
212111
1112111
Platelets
Thrombocytopenia
Platelets
count
Platelets
1112111
Platelets
Platelets
surgery
pooling
1112111
512111
dilution
712111
Platelets
minor surgery
destruction
1112111
production
Platelets
Platelets
production
production
drugs
pancytopenia
immunological
splenomegaly
destruction
autoimmune or alloimmune
against
AB
autoimmune
thiazide
antibodies
immunological
AB
Alloimmune
my own platelets
evan syndrome , alpha methyl dopa ,
Platelets
ITP
AB
%9 0
allergy
platelets
IgG
heparin
population
Thrombosis
thrombosis
DIC
increase destruction
destruction
reticulcytes
decr prod
BM
platlets
destruction
decrease productin
Platelets
platelets
incr or dec
BM
pooling
211 at any moment Platlet
pooling
311
311
splenomegaly
incr or decr
pooling
spleen
Platelets
211
211
spleen
blood
91
spleen
splenomegaly
91
Platelets
platelets
131
spelnomegaly
hypothermia
111
hypothermia
pooling
spleen
we have no idea
splenomegaly or hypothermia
spleen
pooling
dilution
fresh flood
dilution of
Platelets
Platelets
5
ca
platelet thrombocytopenia
2 units of platelets
plaltlet
platelets
dilution of platelets
BM
receptors
ITP
IgG
ITP
IgG Antibodies
macrophage
spleen
platelets
IgG
Platelets
macrophage
Platelets
budding
AB
Clinical picture
CP
petechia <3 ml doesnt blanch , not raised
cerebral hemorrhage
children
acute
within 3
specific
spontenous remission
mild
mild
severe thrombocytopenia
middle age
females
chronic ITP
Mild :D
month
thrombocytopenia
Investigation
Bleeding time
Platelets count
normal clotting time PT ,PTT
IgG
Specific inv
Treatment
Avoid trauma , avoid injury
Avoid unnecessary surgeries
corticosteroids
mild hemorrhage
cerebral hemorrhage
Antibodies
Platelets
bleeding
receptors of macrophages
permenant treatment
danazole
fever
Ab
ITP
lymphoma and leukemia
pooling
aplastic anemia
spleen
splenomegaly or Lymphadenopathy or
IgG
Plasma pharesis
splenectomy
budding
Ab
Antibodies
cyclosporine
ITP
IV immunoglobulins
ITP
ITP
splenomegaly
exclusion
splenomegalo
lyphadenopathy
platelet
ITP
splenomegaly
splenomegaly
ITP
Thromboasthenia
Platelets
function
VWBF
function
defect
Thromboasthenia
glycoptn recptor
Platelets
adhesions
adheiosn
deficeny
inhibition
congenitally
endothelium
toxins
VWB disease
RenalFailur
VWBF
failure
congenital or uremia
adhesion
Bernard
release VWBF
congenitally
congenitally
receptors
VWBF
platelet
aggregations
aggregation
VWBF
receptors
aggregations
fibrin
2B
receptor
aggregations
fibrinogen
congenital afibrinogenia
diphosphate
Afibrinogenmia
fibrin
fibrinogen
congenitally
glanzman disease
1911
receptors
congenital
Dysphybrinogenima
receptors
congenital
receptor
Aspirin
antiplatlet
aggregation
fibrin
thromoxane A2
clopidogrel
ADP
angina
platelets
granules
afibrinogenima
BM
Tirofiban
3 adhesions
glycoptn
defect
storage disease
secretions
granules
secretions
secreting stage
angina :D
granules
Thrombocytosis
primary ya secondry
Platelets
thrombocytosis
polycythemia vera
primary
leukemia
essential hypertension
primary thrombocytosis
Platelets primary
essential thrombocytosis
Platelets
bleeding tendency
non functioning
bleeding tendency
hemorrhage hemolysis bonemarrow irritation
Platelets
non functioning
splenectomy
secondry
Platelets are function
thrombocytosis
ITP causes of asthenia
just causes
decr production
Platelets
destruction of platelet
congenital
coagulation
7 . 9 .11.13
Hemophilia A
VWB 1
7 activate
11
Platelets adhesion
< 11 activate
1
endothelim
12 intrinsic pathway
Liver
ca & factor 8
VWBF
antihemophilic globulin ,
liver
intrinsic
11
factor 8
disease
urine
antihemophilic globulin
Intrinsic pathway
males affected , females carrier
VWBF
hemophilia a
X linked
Clinical picture
joint
joint
calcification
hematoma in muscles
following trauma
Hemorrhage
family history
carrier
female
paternal uncle
maternal uncle
Investigations
ptt
intrinsic
pathway
211 51
1
mild
specific
01 25
moderate
5-25
sever
1-5
very severe
<1
DNa analysis
intrauterine
Treatment
Avoid truma
:D
hemophilic
31
15ml/kg
plasma
051
12
volume overload
1
051
15X30 ..
711
infections
factor 8 resistance
antibodies
antigen
active bleeding
factor 8 resistance
cryoperciptate
IV
room tempreture
=D
31
1
volume overload
volume
genetic engineering
bleeding
periceptate
cryo
crypoerciptate
thrombin
compression
externally
thrombin
Thrombin
VonwilleBrand Disease
urine
factor 8 VWB
VWB disease
actually
investigations
ADH
MCQ
hemophilia A
Hematology
ptt prolonged
ADH
desmopressin
Hemophilia
VWB disease
7